Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
5
EVAX Quote, Financials, Valuation and Earnings
Last price:
$0.90
Seasonality move
:
-43.46%
Day range:
$0.88 - $0.96
52-week range:
$0.85 - $13.61
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.27x
P/B ratio:
72.85x
Volume:
73.1K
Avg. volume:
77K
1-year change:
-86.18%
Market cap:
$5.4M
Revenue:
$73K
EPS (TTM):
-$2.80
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | $73K | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $8.2M | $10.9M | $19.6M | $17.1M | $11.9M | |
| Selling, General & Admin | $2.6M | $5.7M | $6.2M | $8.1M | $10.1M | |
| Other Inc / (Exp) | $56K | $22K | $1.3M | $2.1M | $25K | |
| Operating Expenses | $10.9M | $16.6M | $25.8M | $25.3M | $22.3M | |
| Operating Income | -$10.9M | -$16.6M | -$25.8M | -$25.3M | -$22.2M | |
| Net Interest Expenses | -- | -- | -- | -- | $743K | |
| EBT. Incl. Unusual Items | -$12M | -$16.6M | -$24.7M | -$23.9M | -$22.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$825K | -$1.6M | -$178K | -$772K | -$790K | |
| Net Income to Company | -$11.2M | -$15M | -$24.5M | -$23.2M | -$22.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$11.2M | -$15M | -$24.5M | -$23.2M | -$22.1M | |
| Basic EPS (Cont. Ops) | -$5.83 | -$9.27 | -$12.60 | -$9.80 | -$8.10 | |
| Diluted EPS (Cont. Ops) | -$5.83 | -$9.27 | -$12.60 | -$9.80 | -$8.10 | |
| Weighted Average Basic Share | $1.9M | $1.6M | $1.9M | $2.4M | $2.7M | |
| Weighted Average Diluted Share | $1.9M | $1.6M | $1.9M | $2.4M | $2.7M | |
| EBITDA | -$10.7M | -$16.4M | -$24.2M | -$22.6M | -$21.4M | |
| EBIT | -$10.8M | -$16.5M | -$24.6M | -$23.1M | -$22M | |
| Revenue (Reported) | -- | -- | -- | -- | $73K | |
| Operating Income (Reported) | -$10.9M | -$16.6M | -$25.8M | -$25.3M | -$22.2M | |
| Operating Income (Adjusted) | -$10.8M | -$16.5M | -$24.6M | -$23.1M | -$22M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | $3M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $3M | $4.4M | $4.1M | $2.8M | $2.6M | |
| Selling, General & Admin | $1.7M | $1.5M | $2M | $2.9M | $2.1M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $4.7M | $5.9M | $6.1M | $5.8M | $4.7M | |
| Operating Income | -$4.7M | -$5.9M | -$6.1M | -$5.8M | -$1.7M | |
| Net Interest Expenses | -- | -- | -- | -- | $300K | |
| EBT. Incl. Unusual Items | -$4.6M | -$5.7M | -$5.9M | -$5.9M | -$2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$578K | -$425K | -$175K | -$194K | -$96K | |
| Net Income to Company | -$4M | -$5.3M | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$4M | -$5.3M | -$5.7M | -$5.7M | -$1.9M | |
| Basic EPS (Cont. Ops) | -$2.48 | -$2.70 | -$2.40 | -$2.10 | -$0.40 | |
| Diluted EPS (Cont. Ops) | -$2.48 | -$2.70 | -$2.40 | -$2.10 | -$0.40 | |
| Weighted Average Basic Share | $1.6M | $1.9M | $2.4M | $2.8M | $5.5M | |
| Weighted Average Diluted Share | $1.6M | $1.9M | $2.4M | $2.8M | $5.5M | |
| EBITDA | -$4.6M | -$5.6M | -$5.4M | -$5.7M | -$1.6M | |
| EBIT | -$4.6M | -$5.6M | -$5.4M | -$5.7M | -$1.6M | |
| Revenue (Reported) | -- | -- | -- | -- | $3M | |
| Operating Income (Reported) | -$4.7M | -$5.9M | -$6.1M | -$5.8M | -$1.7M | |
| Operating Income (Adjusted) | -$4.6M | -$5.6M | -$5.4M | -$5.7M | -$1.6M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | $3.3M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $11M | $16.3M | $19.1M | $13.7M | $10.5M | |
| Selling, General & Admin | $4.6M | $6.5M | $7.3M | $10.4M | $7.6M | |
| Other Inc / (Exp) | -- | -- | -- | -$57K | -$1.6M | |
| Operating Expenses | $15.6M | $22.8M | $26.5M | $24.3M | $18.4M | |
| Operating Income | -$15.6M | -$22.8M | -$26.5M | -$24.3M | -$15.1M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$15.6M | -$22.4M | -$23.9M | -$25.3M | -$12.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$1.3M | -$2M | $724K | -$786K | -$690K | |
| Net Income to Company | -- | -$20.4M | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$14.3M | -$20.4M | -$24.7M | -$24.5M | -$11.5M | |
| Basic EPS (Cont. Ops) | -$7.82 | -$11.24 | -$10.80 | -$9.50 | -$2.80 | |
| Diluted EPS (Cont. Ops) | -$7.82 | -$11.24 | -$10.80 | -$9.50 | -$2.80 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -$15.5M | -$21.6M | -$23.7M | -$24.7M | -$11.2M | |
| EBIT | -$15.5M | -$21.6M | -$23.7M | -$24.7M | -$11.2M | |
| Revenue (Reported) | -- | -- | -- | -- | $3.3M | |
| Operating Income (Reported) | -$15.6M | -$22.8M | -$26.5M | -$24.3M | -$15.1M | |
| Operating Income (Adjusted) | -$15.5M | -$21.6M | -$23.7M | -$24.7M | -$11.2M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | $3.2M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $8M | $13.4M | $13M | $9.6M | $8.2M | |
| Selling, General & Admin | $3.9M | $4.7M | $5.8M | $8.1M | $5.7M | |
| Other Inc / (Exp) | -- | -- | -- | -$57K | -$1.6M | |
| Operating Expenses | $11.9M | $18.1M | $18.7M | $17.7M | $13.9M | |
| Operating Income | -$11.9M | -$18.1M | -$18.7M | -$17.7M | -$10.7M | |
| Net Interest Expenses | -- | -- | -- | -- | $484K | |
| EBT. Incl. Unusual Items | -$11.8M | -$17.7M | -$16.9M | -$18.2M | -$7.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$1.1M | -$1.5M | -$599K | -$613K | -$513K | |
| Net Income to Company | -$10.7M | -$16.2M | -$10.6M | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$10.7M | -$16.2M | -$16.3M | -$17.6M | -$6.9M | |
| Basic EPS (Cont. Ops) | -$5.99 | -$8.60 | -$6.90 | -$6.60 | -$1.30 | |
| Diluted EPS (Cont. Ops) | -$5.99 | -$8.60 | -$6.90 | -$6.60 | -$1.30 | |
| Weighted Average Basic Share | $5.5M | $5.6M | $7.1M | $8.1M | $15.4M | |
| Weighted Average Diluted Share | $5.5M | $5.6M | $7.1M | $8.1M | $15.4M | |
| EBITDA | -$11.8M | -$16.8M | -$16M | -$17.5M | -$6.6M | |
| EBIT | -$11.8M | -$16.8M | -$16M | -$17.5M | -$6.6M | |
| Revenue (Reported) | -- | -- | -- | -- | $3.2M | |
| Operating Income (Reported) | -$11.9M | -$18.1M | -$18.7M | -$17.7M | -$10.7M | |
| Operating Income (Adjusted) | -$11.8M | -$16.8M | -$16M | -$17.5M | -$6.6M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $9.6M | $5.8M | $32.2M | $13.2M | $5.6M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $468K | $1.2M | $638K | $2.5M | $1.7M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $11M | $11M | $34.7M | $17M | $8.4M | |
| Property Plant And Equipment | $101K | $221K | $5.2M | $4.7M | $4.3M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $11.1M | $12M | $40.2M | $22M | $12.9M | |
| Accounts Payable | $646K | $3.7M | $2.8M | $2.1M | $2.7M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | $126K | $136K | $159K | |
| Current Portion Of Capital Lease Obligations | $36K | $20K | $314K | $303K | $326K | |
| Other Current Liabilities | $177K | $180K | $46K | $885K | $3M | |
| Total Current Liabilities | $1.7M | $4.9M | $4.3M | $3.8M | $7.1M | |
| Long-Term Debt | -- | -- | $1M | $7.9M | $8.5M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.7M | $4.9M | $7.7M | $13.7M | $17.6M | |
| Common Stock | $2.5M | $2.6M | $3.8M | $3.9M | $5.9M | |
| Other Common Equity Adj | $22.7M | $31.7M | -- | -- | -- | |
| Common Equity | $9.4M | $7M | $32.4M | $8.3M | -$4.7M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $9.4M | $7M | $32.4M | $8.3M | -$4.7M | |
| Total Liabilities and Equity | $11.1M | $12M | $40.2M | $22M | $12.9M | |
| Cash and Short Terms | $9.6M | $5.8M | $32.2M | $13.2M | $5.6M | |
| Total Debt | -- | -- | -- | -- | $8.6M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $7.9M | $11.9M | $17.9M | $2.6M | $4.6M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $1.4M | $2.2M | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $10.4M | $16.3M | $17.9M | $2.6M | $4.6M | |
| Property Plant And Equipment | $166K | $5.2M | -- | -- | -- | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $11.3M | $24.1M | $27.4M | $11.9M | $15.2M | |
| Accounts Payable | $1.5M | $538K | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | $159K | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $38K | $319K | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $3.4M | $3.9M | -- | -- | -- | |
| Long-Term Debt | -- | $1.1M | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $3.4M | $7.5M | $13.9M | $14.7M | $15.2M | |
| Common Stock | $2.6M | $3.1M | -- | -- | -- | |
| Other Common Equity Adj | $29.1M | $55.7M | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $7.9M | $16.7M | $13.5M | -$2.7M | -- | |
| Total Liabilities and Equity | $11.3M | $24.1M | $27.4M | $11.9M | $15.2M | |
| Cash and Short Terms | $7.9M | $11.9M | $17.9M | $2.6M | $4.6M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$11.2M | -$15M | -$24.5M | -$23.2M | -$22.1M | |
| Depreciation & Amoritzation | $81K | $105K | $344K | $571K | $615K | |
| Stock-Based Compensation | $2.4M | $3.4M | $1.4M | $942K | $479K | |
| Change in Accounts Receivable | -$337K | -$2.5M | $1.9M | -$1.5M | $1.1M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$7M | -$12.4M | -$21.9M | -$25.8M | -$17.7M | |
| Capital Expenditures | -- | -- | -- | -- | $87K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$68K | -$393K | -$1.3M | -$268K | -$93K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $152K | -- | -- | $7.8M | $65K | |
| Long-Term Debt Repaid | -$73K | -$74K | -$289K | -$424K | -$697K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$13K | -$128K | -$3.8M | -- | -$432K | |
| Cash From Financing | $9.5M | $8.8M | $49.8M | $7.9M | $10.7M | |
| Beginning Cash (CF) | $7.4M | $9.6M | $5.8M | $32.2M | $13.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $2.4M | -$4M | $26.5M | -$18.2M | -$7.1M | |
| Ending Cash (CF) | $9.6M | $5.8M | $32.2M | $13.2M | $5.6M | |
| Levered Free Cash Flow | -$7.1M | -$12.8M | -$23.3M | -$26.1M | -$17.8M | |
| Period Ending | 2018-06-30 | 2019-06-30 | 2020-06-30 | 2021-06-30 | 2022-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -$3.6M | -$6.8M | -$4.8M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -$2.3M | -$7.5M | -$5.2M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -$45K | -$495K | -$77K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -$18K | -$35K | -$107K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -$221K | |
| Cash From Financing | -- | -- | -$18K | -$35K | -$300K | |
| Beginning Cash (CF) | -- | -- | $6.3M | $27M | $31.4M | |
| Foreign Exchange Rate Adjustment | -- | -- | $106K | -$138K | -$590K | |
| Additions / Reductions | -- | -- | -$2.4M | -$8M | -$5.6M | |
| Ending Cash (CF) | -- | -- | $4.1M | $18.8M | $25.3M | |
| Levered Free Cash Flow | -- | -- | -$2.3M | -$8M | -$5.3M | |
| Period Ending | 2018-06-30 | 2019-06-30 | 2020-06-30 | 2021-06-30 | 2022-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -$19.2M | -$24.2M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -$18.7M | -$23.8M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -$1.1M | -$744K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -$116K | -$429K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -$2.7M | -- | |
| Cash From Financing | -- | -- | -- | $34.1M | $32M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | $14.3M | $7.5M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -$19.8M | -$24.6M | |
| Period Ending | 2020-12-23 | 2021-12-23 | 2022-12-23 | 2023-12-23 | ||
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
Get EVAX Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
EVAX
Sector
P/E ratio
--
25.86x
PEG ratio
--
0.00x
P/B ratio
72.85x
1.85x
Price / LTM sales
1.27x
1.86x
Growth Metrics
EVAX
Sector
Revenue growth
--
7.28%
Earnings growth
--
1.82%
Revenue (5-year growth)
--
8.73%
Earnings forecast
-$0.12
-$0.20
Profitability
EVAX
Sector
Profitability FY 2024
--
$57.1M
Return on invested capital
-238.97%
-14.06%
Return on assets
-69.51%
-11.77%
Return on equity
--
-14.78%
Earnings Date
Last Earnings Date
Oct
31
Next Earnings Date
Mar
27
Estimated Next Earnings Date
Jan
30
Balance Sheet
EVAX
Sector
Total cash
$4.6M
$47M
Short term investments
--
$45.2M
Total assets
$12.9M
$142.6M
Long term debt
--
$6.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
